170 related articles for article (PubMed ID: 1159010)
1. Gas chromatographic-mass fragmentographic determation of "steady-state" plasma levels of imipramine and desipramine in chronically treated patients.
Belvedere G; Burti L; Frigerio A; Pantarotto C
J Chromatogr; 1975 Sep; 111(2):313-21. PubMed ID: 1159010
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of imipramine, desipramine and their deuterium-labelled analogues in biological fluids by capillary gas chromatography-mass spectrometry.
Sasaki Y; Baba S
J Chromatogr; 1988 Apr; 426(1):93-101. PubMed ID: 3384883
[TBL] [Abstract][Full Text] [Related]
3. Gas-chromatographic analysis for therapeutic concentration of imipramine and disipramine in plasma, with use of a nitrogen detector.
Bailey DN; Jatlow PI
Clin Chem; 1976 Oct; 22(10):1697-701. PubMed ID: 975516
[TBL] [Abstract][Full Text] [Related]
4. A sensitive method for the simultaneous determination in biological fluids of imipramine and desipramine or clomipramine and N-desmethylclomipramine by gas chromatography mass spectrometry.
Alkalay D; Volk J; Carlsen S
Biomed Mass Spectrom; 1979 May; 6(5):200-4. PubMed ID: 476283
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites.
Sutfin TA; Jusko WJ
J Pharm Sci; 1979 Jun; 68(6):703-5. PubMed ID: 458567
[TBL] [Abstract][Full Text] [Related]
6. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry.
Narasimhachari N; Saady J; Friedel RO
Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a new GLC-AFID method with a GLC-MS selected ion monitoring technique and a radioimmunoassay for the determination of plasma concentrations of imipramine and desipramine.
Midha KK; Charette C; Cooper JK; McGilveray IJ
J Anal Toxicol; 1980; 4(5):237-43. PubMed ID: 7442136
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous analysis of imipramine and its metabolite desipramine in biological fluids.
Craig JC; Gruenke LD; Nguyen TL
J Chromatogr; 1982 Apr; 239():81-6. PubMed ID: 7096509
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of imipramine and desipramine by selected ion recording with deuterated internal standards.
Claeys M; Muscettola G; Markey SP
Biomed Mass Spectrom; 1976 Jun; 3(3):110-6. PubMed ID: 990418
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of imipramine and its metabolite desipramine in human plasma by capillary gas chromatography with mass-selective detection.
Pommier F; Sioufi A; Godbillon J
J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):147-58. PubMed ID: 9448071
[TBL] [Abstract][Full Text] [Related]
11. Decreased plasma concentrations of imipramine and desipramine following cholestyramine intake in depressed patients.
Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
Ther Drug Monit; 1994 Aug; 16(4):432-4. PubMed ID: 7974637
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of imipramine and desmethylimipramine in human plasma by mass fragmentography.
Pantarott C; Belvedere G; Frigerio A
Z Klin Chem Klin Biochem; 1974 May; 12(5):224-5. PubMed ID: 4440110
[No Abstract] [Full Text] [Related]
13. Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.
Foglia JP; Sorisio D; Perel JM
J Chromatogr; 1991 Dec; 572(1-2):247-58. PubMed ID: 1818058
[TBL] [Abstract][Full Text] [Related]
14. Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.
Potter WZ; Zavadil AP; Kopin IJ; Goodwin FK
Arch Gen Psychiatry; 1980 Mar; 37(3):314-20. PubMed ID: 7362419
[TBL] [Abstract][Full Text] [Related]
15. The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients.
Schenk PW; van Vliet M; Mathot RA; van Gelder T; Vulto AG; van Fessem MA; Verploegh-Van Rij S; Lindemans J; Bruijn JA; van Schaik RH
Pharmacogenomics J; 2010 Jun; 10(3):219-25. PubMed ID: 19884907
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of imipramine, desipramine and their 2- and 10-hydroxylated metabolites in human plasma and urine by high-performance liquid chromatography.
Chen AG; Wing YK; Chiu H; Lee S; Chen CN; Chan K
J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):153-8. PubMed ID: 9200529
[TBL] [Abstract][Full Text] [Related]
17. Mass fragmentographic determination of lofepramine and its metabolites in human plasma and urine using deuterated internal standards.
Matsubayashi K; Hakusui H; Sano M
J Chromatogr; 1977 Nov; 143(6):571-80. PubMed ID: 914949
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis for tricyclic antidepressant drugs in plasma or serum by gas chromatography-chemical-ionization mass spectrometry.
Chinn DM; Jennison TA; Crouch DJ; Peat MA; Thatcher GW
Clin Chem; 1980 Jul; 26(8):1201-4. PubMed ID: 7389093
[TBL] [Abstract][Full Text] [Related]
19. Reversed-phase liquid chromatography and gas chromatography/mass fragmentography compared for determination of tricyclic antidepressant drugs.
Breutzmann DA; Bowers LD
Clin Chem; 1981 Nov; 27(11):1907-11. PubMed ID: 7296842
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics.
Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T
Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
